Paul Vauterin Moves from CTO to COO at BioLizard

Paul Vauterin Moves from CTO to COO at BioLizard

Embracing the next phase of AI-driven innovation in life sciences Paul Vauterin has transitioned from Chief Technology Officer (CTO) to Chief Operating Officer (COO) at BioLizard, reflecting a shift in focus towards helping organisations integrate AI into their...
BioLizard has been listed as a Trends Gazelle

BioLizard has been listed as a Trends Gazelle

As a fast-growing company, BioLizard has been recognised as one of the companies to watch in 2025!  This recognition is part of a joint initiative by Trends, Change the Game, and Kanaal Z, which closely monitors companies achieving the greatest growth based on value...
AI in biotech: Fashioning the future of R&D and IP

AI in biotech: Fashioning the future of R&D and IP

In today’s dynamic biotech and biomedicine sectors, the transformative power of artificial intelligence (AI) stands at the forefront in R&D. To leverage AI to its full potential, it’s key to understand the nuanced, strategic advancements it brings –...